SCHEMBL1319360

SCHEMBL1319360

O=C(Nc1cc(-c2ccccc2)ccc1C(=O)O)c1ccc(OCCN2CCOCC2)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
KDR P35968 3/20 0.54
HDAC1 Q13547 2/20 0.50
MCL1 Q07820 1/20 0.48
MET P08581 1/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
LMNA P02545 1/20 0.47
HDAC2 Q92769 1/20 0.47
PPARG P37231 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
PRKAB2 O43741 1/20 0.46
PRKAG1 P54619 1/20 0.46
PRKAA2 P54646 1/20 0.46
PRKAA1 Q13131 1/20 0.46
PRKAG3 Q9UGI9 1/20 0.46
PRKAG2 Q9UGJ0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1318223 0.96 MCL1 (0.51) NPC1RAB9AKDRHDAC1MCL1
SCHEMBL12117946 0.94 NPC1 (0.53) NPC1RAB9AKDRHDAC1MCL1
Hydrochloric Acid SCHEMBL1319167 0.93 NPC1 (0.55) NPC1RAB9AKDRHDAC1MCL1
SCHEMBL12117974 0.90 MAOB (0.53) NPC1RAB9AKDRHDAC1MET
SCHEMBL12117972 0.89 KDR (0.49) NPC1RAB9AKDRHDAC1MET
SCHEMBL1318226 0.88 KDR (0.48) NPC1RAB9AKDRHDAC1MCL1
SCHEMBL1317105 0.87 MAOB (0.50) NPC1RAB9AKDRHDAC1MET
SCHEMBL13205904 0.86 NPC1 (0.49) NPC1RAB9AKDRMCL1PPARG
SCHEMBL1318225 0.86 MCL1 (0.49) NPC1RAB9AKDRHDAC1MCL1
SCHEMBL12117945 0.85 LTA4H (0.52) KDRHDAC1MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed
WO-2010087430-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 NPC1 4343/4885RAB9A 2216/4885KDR 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.